Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · Real-Time Price · USD

27.11

-0.43 (-1.56%)

Aug 21, 2026, 4:00 PM EDT - Market closed

Collegium Pharmaceutical Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	808.21	780.57	631.45	566.77	463.93	276.87
Revenue Growth	14.31%	23.61%	11.41%	22.17%	67.56%	-10.69%
Gross Profit	722.93	693.64	547.92	471.93	345.74	217.8
Operating Income	171.65	193.09	199.63	175.46	38.11	22.21
Net Income	47.92	62.87	69.19	48.16	-25	71.52
Earnings Per Share	1.41	1.73	1.86	1.29	-0.74	1.86
EPS Growth	32.73%	-6.56%	43.56%	-	-	144.25%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	129.47	386.68	162.76	310.55	173.69	186.43
Total Debt	1,218	936.43	979.91	674.28	709.18	258.75
Net Cash (Debt)	-1,088	-549.75	-817.15	-363.74	-535.49	-72.32
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-30.07	-13.85	-20.21	-8.70	-15.83	-1.76

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	329.92	329.32	204.98	274.75	124.23	103.56
Capital Expenditures	-1.64	-1.74	-1.65	-0.46	-1.62	-1.94
Free Cash Flow	328.28	327.58	203.33	274.29	122.61	101.61
Free Cash Flow Growth	62.67%	61.11%	-25.87%	123.71%	20.66%	14.95%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	89.45%	88.86%	86.77%	83.27%	74.52%	78.66%
Operating Margin	21.24%	24.74%	31.61%	30.96%	8.21%	8.02%
Pretax Margin	9.61%	11.87%	15.61%	13.36%	-6.22%	-1.22%
Profit Margin	5.93%	8.05%	10.96%	8.50%	-5.39%	25.83%
FCF Margin	40.62%	41.97%	32.20%	48.39%	26.43%	36.70%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	19.29	23.28	13.35	20.84	-	9.09
Forward PE	3.85	6.11	4.54	5.57	4.01	4.57
P/FCF Ratio	2.69	4.47	4.54	3.66	6.35	6.40
PS Ratio	1.09	1.88	1.46	1.77	1.68	2.35